ArticleTherapeutic advances in medical oncology2020

Risk factors for MEK-associated retinopathy in patients with advanced melanoma treated with combination BRAF and MEK inhibitor therapy.

Andrew E C Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.